The Methodist Cancer Center — Omaha, Nebraska

The Methodist Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

The Methodist Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Sponsors: Novartis.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Methodist Cancer Center?

The Methodist Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Methodist Cancer Center conducted?

The Methodist Cancer Center has 1 clinical trials on record. Their work covers Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms.

Is The Methodist Cancer Center accredited by Crixeo Health?

The Methodist Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Methodist Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.